Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Unknown Primary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00302588
What this trial is testing

The Final Diagnosis and Treatment Result of Metastatic Cervical Carcinoma of Unknown Primary

Who this might be right for
Metastasis Cervical Lymph Nodes of Unknown Primary Carcinoma
National Taiwan University Hospital 100
Not applicableUnknownNCT04025970
What this trial is testing

Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP

Who this might be right for
Neoplasms, Unknown PrimaryCancer
Christer Ericsson 200
Testing effectiveness (Phase 2)Study completedNCT00193622
What this trial is testing

Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site

Who this might be right for
Neoplasms, Unknown Primary
SCRI Development Innovations, LLC 50
Not applicableUnknownNCT05263700
What this trial is testing

FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary Site
Peter MacCallum Cancer Centre, Australia 150
Large-scale testing (Phase 3)Looking for participantsNCT07761429
What this trial is testing

A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)

Who this might be right for
Cancer of Unknown Primary Site
Shandong New Time Pharmaceutical Co., LTD 402
Testing effectiveness (Phase 2)Study completedNCT02820857
What this trial is testing

Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer

Who this might be right for
Neuroendocrine Carcinomas
Hospices Civils de Lyon 153
Early research (Phase 1)Active Not RecruitingNCT04459273
What this trial is testing

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Who this might be right for
Bladder CarcinomaCervical CarcinomaCholangiocarcinoma+13 more
Jonsson Comprehensive Cancer Center 26
Large-scale testing (Phase 3)UnknownNCT00003558
What this trial is testing

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

Who this might be right for
Carcinoma of Unknown Primary
Academisch Ziekenhuis Maastricht 140
Testing effectiveness (Phase 2)UnknownNCT04131621
What this trial is testing

Nivolumab/Ipilimumab in Second Line CUP-syndrome

Who this might be right for
Cancer of Unknown Primary Site
University Hospital Heidelberg 194
Testing effectiveness (Phase 2)Study completedNCT04133948
What this trial is testing

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07434180
What this trial is testing

Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary

Who this might be right for
Cancer of Unknown Primary
Peter MacCallum Cancer Centre, Australia 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269
What this trial is testing

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Who this might be right for
Malignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)WithdrawnNCT00119314
What this trial is testing

Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

Who this might be right for
Carcinoma of Unknown Primary
University of Medicine and Dentistry of New Jersey
Not applicableStudy completedNCT00530283
What this trial is testing

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Who this might be right for
Squamous Cell Cancer
AHS Cancer Control Alberta 20
Testing effectiveness (Phase 2)Study completedNCT05024968
What this trial is testing

Sintilimab in Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary Site
M.D. Anderson Cancer Center 10
Not applicableStudy completedNCT02628379
What this trial is testing

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

Who this might be right for
Neoplasms, Unknown PrimaryCUPMetastatic Disease+3 more
Foundation Medicine 125
Early research (Phase 1)Looking for participantsNCT07006727
What this trial is testing

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaLarge Cell Neuroendocrine Carcinoma of the LungNeuroendocrine Prostate Cancer+8 more
Novartis Pharmaceuticals 116
Testing effectiveness (Phase 2)Study completedNCT00191503
What this trial is testing

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

Who this might be right for
Adenocarcinoma
Eli Lilly and Company 30
Early research (Phase 1)Looking for participantsNCT04754321
What this trial is testing

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Who this might be right for
Head and Neck Carcinoma of Unknown PrimaryLocally Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+3 more
Ohio State University Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06869174
What this trial is testing

Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary
Zhiguo Luo, MD, PhD 50
Next Page